| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/09/2005 | EP1087951B1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 02/09/2005 | EP1079813B1 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 02/09/2005 | EP1071417B1 Use of cannabidiol as anti-inflammatory agent |
| 02/09/2005 | EP0957927B1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation |
| 02/09/2005 | CN1578838A Method and means for producing protein with prospective post-translation modification |
| 02/09/2005 | CN1578786A Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/09/2005 | CN1578782A Silicon compounds |
| 02/09/2005 | CN1578778A Tetrahydropyran derivatives and their use as therapeutic agents |
| 02/09/2005 | CN1578773A Methods and compositions of novel triazine compounds |
| 02/09/2005 | CN1578768A Anthranilic acid amides and pharmaceutical use thereof |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578724A System, method and apparatus for producing dosage forms |
| 02/09/2005 | CN1578665A Type 4 phosphodiesterase inhibitors and uses thereof |
| 02/09/2005 | CN1578661A Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 02/09/2005 | CN1578647A Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 02/09/2005 | CN1578626A Multivesicular emulsion topical delivery systems |
| 02/09/2005 | CN1188528C Intercellular adhesion molecule-3 and its binding ligands |
| 02/09/2005 | CN1188405C New Morpholinobenzamide salts |
| 02/09/2005 | CN1188404C Cyclic compound |
| 02/09/2005 | CN1188403C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/09/2005 | CN1188389C Benzamide derivatives for the treatment of diseases caused by cytokines |
| 02/09/2005 | CN1188388C Aminobenzophenones as inhibitors of interleukin and TNF |
| 02/09/2005 | CN1188165C Method for treating pain by peripheral administration of neurotoxin |
| 02/09/2005 | CN1188164C Compositions and method for regulating phagocytosis and ICAM-1 expression |
| 02/09/2005 | CN1188154C Quick-acting antalgesic-antipruritic tincture and preparing method thereof |
| 02/09/2005 | CN1188151C Analgesic injection |
| 02/09/2005 | CN1188149C Traditional Chinese medicine powder with functions of activating channels, relieving pain, dispelling wind-evil and strengthening-bone |
| 02/09/2005 | CN1188148C Process for preparing staltic-antagic medicine to treat trauma |
| 02/09/2005 | CN1188140C Reduction of oxidative stress factors |
| 02/09/2005 | CN1188139C Bee glue purifying technological process |
| 02/09/2005 | CN1188134C Preparation having increased in vivo tolerability |
| 02/09/2005 | CN1188113C Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/08/2005 | US6852889 Antioxidant nitroxides and nitrones as therapeutic agents |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852837 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852749 Pyrazolidinol compounds |
| 02/08/2005 | US6852748 Derivatives of 6,7-dihydro-5H-imidazo(1,2- alpha )imidazole-3- sulfonyl)-pyrrolidine-2-carboxylic acid amide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment |
| 02/08/2005 | US6852744 Pyrrolidine derivatives and their use as chymase inhibitor |
| 02/08/2005 | US6852740 Treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I Mitogen-activated protein kinases (MAP) is a family of proline- directed serine/threonine kinases that activate their |
| 02/08/2005 | US6852738 Potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compoundsare for treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, |
| 02/08/2005 | US6852734 Indole wherein A is an oxygen atom or a nitrogen atom which nitrogen atom is optionally substituted with an alkyl group, and (i) R1 and R2 each stand for a hydrogen atom or an alkyl group, independently, or (ii) R1 and R2 as taken together form |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852729 Macrolides |
| 02/08/2005 | US6852727 Inhibitors of Janus protein tyrosine kinases (Jak), and as such are useful as immunosuppressants, and in the treatment of diseases including asthma, allergies, autoimmune diseases. |
| 02/08/2005 | US6852726 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852720 Thiazol-2-yl-imine compounds as PDE-7 inhibitors |
| 02/08/2005 | US6852719 Glucocorticoid receptor modulators |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852712 Controlling cell differentiation; antiinflammatory agents |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852486 Detection of leukocyte antigen in sample; obtain cell sample, incubate with bindng protein, detect bound protein, presence of bound protein indicates leukocyte antigen presence |
| 02/03/2005 | WO2005010154A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 02/03/2005 | WO2005009995A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009994A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009992A1 Cyclohexanecarboxylic acid compound |
| 02/03/2005 | WO2005009988A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 02/03/2005 | WO2005009987A1 Piperidine compounds and pharmaceutical compositions containing them |
| 02/03/2005 | WO2005009973A1 5-membered heterocycle-based p38 kinase inhibitors |
| 02/03/2005 | WO2005009968A1 Quinoline derivates and their use in therapy |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2005009480A2 Implants containing codrugs |
| 02/03/2005 | WO2005009438A1 Nicotinamide compounds useful as pde4 inhibitors |
| 02/03/2005 | WO2005009431A1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 02/03/2005 | WO2005009427A1 Curative medicine for allergosis |
| 02/03/2005 | WO2005009421A2 The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity |
| 02/03/2005 | WO2005009389A2 Anaplastic lymphoma kinase modulators and methods of use |
| 02/03/2005 | WO2004085384A3 Bis-aryl sulfonamides |
| 02/03/2005 | WO2003094859A3 Epha2 monoclonal antibodies and methods of use thereof |
| 02/03/2005 | WO2003039342A3 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145 |
| 02/03/2005 | WO2002096360A3 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 02/03/2005 | US20050027129 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/03/2005 | US20050027125 Intensifiers of adenosine receptors for cardiac arrhythmia |
| 02/03/2005 | US20050027121 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027016 Polyamine compounds and compositions for use in conjection with cancer therapy |
| 02/03/2005 | US20050027013 LTA4 hydrolase inhibitors |
| 02/03/2005 | US20050027009 New derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/03/2005 | US20050026990 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders |
| 02/03/2005 | US20050026988 Cyclopenta'b! indole derivatives as spla inhibitors |
| 02/03/2005 | US20050026980 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseases |
| 02/03/2005 | US20050026979 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 02/03/2005 | US20050026975 Such as ethyl 4-chloroacetamido-N-(3,4-dichlorobenzyl)indole-2-carboxylate use in the treatment of disease mediated by monocyte chemoattractant protein-1 |
| 02/03/2005 | US20050026967 Inhibitors of c-jun N terminal kinases (JNK) and other protein kinases |
| 02/03/2005 | US20050026963 Pyrazole substituted directly, or by a bridge, with a heteroaryl group containing N adjacent to the point of connection of the heteroaryl useful in the treatment of psychiatric and mood disorders such as, schizophrenia, anxiety, depression, bipolar disorder, circadian rhythm and sleep disorders |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/03/2005 | US20050026942 Chemokine receptor binding heterocyclic compounds |
| 02/03/2005 | US20050026941 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 02/03/2005 | US20050026926 N, N'-disubstituted piperazine compounds and their use as analgesics |
| 02/03/2005 | US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer |
| 02/03/2005 | US20050026904 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050026845 Pharmaceutical/cosmetic compositions comprising the lysine-D-proline-valine tripeptide |
| 02/03/2005 | US20050026841 Hab18g/cd147 its antagonist and application |
| 02/03/2005 | US20050026840 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics |
| 02/03/2005 | US20050026824 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 02/03/2005 | US20050026822 Human 3 relaxin |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |